(Q45194924)

English

Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial

scientific article published in December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 December 2017

Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial (English)

1 reference

Europe PubMed Central

10 December 2017

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

erectile dysfunction

1 reference

based on heuristic

inferred from title

author name string

Culley C Carson

1

1 reference

Europe PubMed Central

10 December 2017

Dimitrios G Hatzichristou

2

1 reference

Europe PubMed Central

10 December 2017

Serge Carrier

3

1 reference

Europe PubMed Central

10 December 2017

Douglas Lording

4

1 reference

Europe PubMed Central

10 December 2017

Peter Lyngdorf

5

1 reference

Europe PubMed Central

10 December 2017

Philip Aliotta

6

1 reference

Europe PubMed Central

10 December 2017

Stephen Auerbach

7

1 reference

Europe PubMed Central

10 December 2017

Myron Murdock

8

1 reference

Europe PubMed Central

10 December 2017

H Jeffrey Wilkins

9

1 reference

Europe PubMed Central

10 December 2017

Trish A McBride

10

1 reference

Europe PubMed Central

10 December 2017

Michael W Colopy

11

1 reference

Europe PubMed Central

10 December 2017

Patient Response with Vardenafil in Slidenafil Non-Responders (PROVEN) Study Group

12

1 reference

Europe PubMed Central

10 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2004

1 reference

Europe PubMed Central

10 December 2017

BJU International

1 reference

Europe PubMed Central

10 December 2017

94

1 reference

Europe PubMed Central

10 December 2017

9

1 reference

Europe PubMed Central

10 December 2017

1301-1309

1 reference

Europe PubMed Central

10 December 2017

Erectile dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Efficacy, safety, and use of sildenafil in urologic practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Safety and Efficacy of Vardenafil for the Treatment of Men With Erectile Dysfunction After Radical Retropubic Prostatectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Relationship between patient self-assessment of erectile function and the erectile function domain of the international index of erectile function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Salvage of sildenafil failures referred from primary care physicians

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05161.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2004.05161.X

1 reference

Europe PubMed Central

10 December 2017

1 reference

Europe PubMed Central

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45194924&oldid=2069690184"